Window prophylaxis for preventing TB in children
Part of Infections clinical trials.
This trial tests if a short course of medication can prevent tuberculosis (TB) in children and teenagers who have been in close contact with someone who has active TB. The goal is to see if this approach can stop them from developing the disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 5 and 17 years old.
- You live with or have had close contact with someone recently diagnosed with TB that was confirmed by lab tests.
- You do not currently have any signs of active TB, like a cough for weeks, fever, or night sweats.
- You are not pregnant or breastfeeding.
- You do not have a weakened immune system, such as from HIV or certain medications.
- You have never taken medicine for TB before and have not had a TB skin test in the past.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a very short (one-month) medicine course to prevent tuberculosis (TB) in students and school staff who have been exposed to someone with active TB. If you have latent TB infection (the germs are in your body but you're not sick), this treatment aims to stop it from turning into active TB disease.
This trial tests two shorter treatments (1HP or 3HR) to prevent TB infection from becoming active disease. It is for adults who live with someone who has drug-sensitive TB and have a positive test for TB infection.
This study tests a daily combination of two medicines, rifapentine and isoniazid (called 1HP), to prevent tuberculosis (TB) in children under 13 years old. It includes children who have been exposed to TB or are at high risk, both those living with HIV and those without HIV.
This trial tests a shorter, safer treatment for people with latent TB infection (TB germs in your body but not making you sick). The goal is to prevent you from getting sick with active TB later.
This trial tests whether providing tuberculosis preventive treatment at home, instead of at a clinic, can help protect children under 15 who live with an adult who has recently been diagnosed with pulmonary TB. The goal is to make it easier for families to access care and stop TB from spreading.
This trial tests a shorter treatment for children with tuberculosis (TB) that is not drug-resistant. It aims to find out if a shorter regimen works as well as the standard longer one, making treatment easier for children and their families.
Hear when a new Tuberculosis Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.